10:31 a.m. ET -- Biogen Inc. and Eisai Co. are two of the most talked about companies in the U.S. across all news items in the last 12 hours, according to Factiva data. The U.S. Food and Drug Administration on Friday granted conditional approval to the companies' lecanemab, the most promising drug to date in a new class of medicines that may help slow cognitive decline caused by Alzheimer's disease. Dow Jones & Co. owns Factiva. (colin.kellaher@wsj.com).


(END) Dow Jones Newswires

01-09-23 1046ET